Should Investors Be Worried About Amgen's Q1 Results?
Shares of healthcare company Amgen (NASDAQ: AMGN) have been falling since it released its latest quarterly results on April 27. Although the company generated positive year-over-year revenue growth, earnings declined during the period.
It wasn't a great start to the year, but is it enough to worry investors and to potentially justify selling shares of this high-yielding dividend stock? Here's what was behind the numbers.
Image source: Getty Images.
Source Fool.com